Chris Williams
Vermögen: 41 729 $ am 31.07.2026
Vermögen: 41 729 $ am 31.07.2026
Chris Williams is Chief Business Development Officer & Senior VP at Autolus Therapeutics Plc since 2024.
Former roles include Non-Executive Director at Autolus Ltd. and Director at Orchard Therapeutics (Europe) Ltd. Education includes graduate studies at Imperial College London and undergraduate studies at the University of Cardiff.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2026 | 28’006 ( 0.02% ) | 41 729 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Corporate Officer/Principal | 01.02.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Direktor/Vorstandsmitglied | - |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cardiff
University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen